Kezar Life Sciences Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 47
Employees
  • Stock Symbol
  • KZR
Stock Symbol
  • Share Price
  • $5.65
  • (As of Thursday Closing)

Kezar Life Sciences General Information

Description

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Contact Information

Website
www.kezarlifesciences.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 4000 Shoreline Court
  • Suite 300
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Kezar Life Sciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kezar Life Sciences Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.65 $5.65 $4.24 - $7.40 $272M 48.1M 278K -$0.92

Kezar Life Sciences Financials Summary

In Thousands,
USD 		TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 151,492 97,265 (1,918) 338,199
Revenue 0 0 0 0
EBITDA (45,320) (41,406) (36,041) (24,036)
Net Income (44,724) (41,742) (35,087) (23,167)
Total Assets 152,337 151,842 89,513 114,682
Total Debt 5,219 5,464 6,364 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kezar Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kezar Life Sciences‘s full profile, request access.

Request a free trial

Kezar Life Sciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Kezar Life Sciences‘s full profile, request access.

Request a free trial

Kezar Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel sma
Drug Discovery
South San Francisco, CA
47 As of 2020
00000
000000000 00000

00000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000 000000000
Rockville, MD
000 As of 0000
00000
000000000 00000

00000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000 000000000
San Francisco, CA
00 As of 0000
0000
0000000 0000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kezar Life Sciences Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MacroGenics Formerly VC-backed Rockville, MD 000 00000 000000000 00000
00000000 000000000 Private Equity-Backed San Francisco, CA 00 0000 0000000 0000 0000
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00.000 00000000 00.000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 30 competitors. Get the full list »

Kezar Life Sciences Executive Team (9)

Name Title Board Seat Contact Info
John Fowler Chief Executive Officer & Board Member
Marc Belsky Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Christopher Kirk Ph.D Chief Scientific Officer & Board Member
Jack Taunton Ph.D Co-Founder
Vassiliki Economides Senior Vice President, Strategy and External Affairs
You’re viewing 5 of 9 executive team members. Get the full list »

Kezar Life Sciences Board Members (10)

Name Representing Role Since
Christopher Kirk Ph.D Kezar Life Sciences Chief Scientific Officer & Board Member 000 0000
Elizabeth Garner Self Board Member 000 0000
Franklin Berger Self Board Member 000 0000
Graham Cooper Self Board Member 000 0000
Jason Dinges Ph.D Morningside Group Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Kezar Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kezar Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kezar Life Sciences‘s full profile, request access.

Request a free trial